Prophylactic Radiofrequency Left Atrial Posterior Wall Isolation to Prevent Atrial Fibrillation After Cardiac Surgery

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorVasily I. Kaleda

About this trial

The goal of this clinical trial is to learn if an epicardial radiofrequency left atrial posterior wall isolation (box lesion ablation) prevents atrial fibrillation after cardiac surgery. The main question it aims to answer is:

\- Does box lesion ablation lower the number of patients experiencing de-novo atrial fibrillation requiring any treatment after cardiac surgery? Researchers will compare box lesion ablation to no ablation to see if ablation prevents postoperative atrial fibrillation.

Participants will undergo ablation or no ablation at the time of other cardiac surgery.

Data will be collected while in hospital. Additional information will be collected on 30th day after surgery by telephone call or during a visit.

Eligibility criteria

Qualifiers

All patients undergoing cardiac surgery by a single surgeon (V.K.)

Informed consent

Disqualifiers

History of atrial fibrillation/flutter

Minimally invasive approach

Off-pump surgery

Emergent/salvage surgery

Trial design

Treatments tested in this trial

  • Radiofrequency ablation

Treatment groups

216 Participants
are divided into 2 treatment groups

Sponsors and collaborators

Vasily I. Kaleda

Lead sponsor

Yudin Hospital

Sponsor institution